Lexaria Bioscience Corp (LEXX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.35M
Last updated: Nov 17, 2026 at 11:05 AM ET
Lexaria Bioscience Corp (LEXX) Earnings: Report Dates and Results
Lexaria Bioscience (LEXX) is expected to report earnings on Nov 26, 2026. In the quarter ended May 31, 2026, Lexaria Bioscience reported EPS of -$0.08, below the -$0.06 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
LEXX has an expected report date of Nov 26, 2026.
Earnings History
Of the 20 quarters below that had an estimate, LEXX beat 8, missed 10 and matched 2. The widest gap in the table came in the quarter ended May 31, 2025, when EPS landed 50.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2026 | -$0.08 | -$0.06 | -$0.06 - -$0.06 | -33.33% | Miss | N/A | 1 | 1 up, 0 down | Jul 13, 2026 | N/A |
| Feb 28, 2026 | -$0.06 | -$0.07 | -$0.07 - -$0.07 | +14.29% | Beat | N/A | 1 | 1 up, 0 down | Apr 13, 2026 | $20000 |
| Nov 30, 2025 | -$0.07 | -$0.13 | -$0.13 - -$0.13 | +46.15% | Beat | N/A | 1 | 1 up, 0 down | Jan 13, 2026 | N/A |
| Aug 31, 2025 | -$0.14 | -$0.16 | -$0.18 - -$0.14 | +9.68% | Beat | N/A | 3 | 0 up, 0 down | Nov 26, 2025 | $174000 |
| May 31, 2025 | -$0.21 | -$0.14 | N/A | -50.00% | Miss | N/A | N/A | 0 up, 0 down | Jul 14, 2025 | $174000 |
| Feb 28, 2025 | -$0.15 | -$0.16 | N/A | +6.25% | Beat | N/A | N/A | 0 up, 0 down | Apr 14, 2025 | $174000 |
| Nov 30, 2024 | -$0.16 | -$0.12 | N/A | -33.33% | Miss | N/A | N/A | 0 up, 0 down | Jan 10, 2025 | $183923 |
| Aug 31, 2024 | -$0.15 | -$0.11 | N/A | -36.36% | Miss | N/A | N/A | 0 up, 0 down | Nov 26, 2024 | $84000 |
| May 31, 2024 | -$0.13 | -$0.09 | -$0.13 - -$0.05 | -44.44% | Miss | N/A | 3 | 0 up, 0 down | Jul 12, 2024 | $84000 |
| Feb 29, 2024 | -$0.06 | -$0.10 | -$0.10 - -$0.10 | +40.00% | Beat | N/A | 1 | 0 up, 0 down | Apr 9, 2024 | $145000 |
| Nov 30, 2023 | -$0.13 | -$0.11 | -$0.11 - -$0.11 | -18.18% | Miss | N/A | 1 | 1 up, 0 down | Jan 12, 2024 | $151278 |
| Aug 31, 2023 | -$0.12 | -$0.13 | -$0.17 - -$0.10 | +7.69% | Beat | N/A | 2 | 0 up, 0 down | Nov 21, 2023 | N/A |
| May 31, 2023 | -$0.37 | -$0.25 | N/A | -48.00% | Miss | N/A | N/A | N/A | Jul 14, 2023 | $77707 |
| Feb 28, 2023 | -$0.22 | -$0.22 | N/A | +0.86% | Beat | N/A | N/A | 0 up, 0 down | Apr 14, 2023 | $20025 |
| Nov 30, 2022 | -$0.30 | -$0.30 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Jan 17, 2023 | $97735 |
| Aug 31, 2022 | -$0.24 | -$0.21 | N/A | -14.29% | Miss | N/A | N/A | 0 up, 0 down | Nov 25, 2022 | $111150 |
| May 31, 2022 | -$0.41 | -$0.28 | -$0.28 - -$0.28 | -46.43% | Miss | N/A | 1 | 0 up, 0 down | Jul 14, 2022 | $99717 |
| Feb 28, 2022 | -$0.25 | -$0.21 | N/A | -19.05% | Miss | -327.3% | 1 | 0 up, 0 down | Apr 11, 2022 | $30650 |
| Nov 30, 2021 | -$0.35 | -$0.35 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Jan 14, 2022 | $13880 |
| Aug 31, 2021 | -$0.22 | -$0.23 | -$0.23 - -$0.23 | +4.35% | Beat | N/A | 1 | 0 up, 0 down | Nov 29, 2021 | $31021 |
| May 31, 2021 | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 15, 2021 | $204055 |
| Feb 28, 2021 | $0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 14, 2021 | $192006 |
| Nov 30, 2020 | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 14, 2021 | $295656 |
| Aug 31, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 15, 2020 | $133739 |
| May 31, 2020 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2020 | $36423 |
| Feb 29, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 3, 2020 | $37549 |
| Nov 30, 2019 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 8, 2020 | $10332 |
| Aug 31, 2019 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 | $125121 |
| May 31, 2019 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 8, 2019 | $59931 |
| Feb 28, 2019 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 15, 2019 | $15349 |
| Nov 30, 2018 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 11, 2019 | $22209 |
| Aug 31, 2018 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2018 | $96354 |
| May 31, 2018 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 13, 2018 | $140340 |
| Feb 28, 2018 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 12, 2018 | $171958 |
| Nov 30, 2017 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 12, 2018 | $24635 |
| Aug 31, 2017 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 27, 2017 | $12559 |
| May 31, 2017 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 13, 2017 | $29253 |
| Feb 28, 2017 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 13, 2017 | $12602 |
| Nov 30, 2016 | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 13, 2017 | $9225 |
| Aug 31, 2016 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 28, 2016 | $8562 |
Annual EPS
EPS for the fiscal year ended Aug 31, 2026 was -$0.21, after -$0.66 the year before. It was -$0.49 for the year ended Aug 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Aug 31, 2026 | -$0.21 | N/A |
| Aug 31, 2025 | -$0.66 | N/A |
| Aug 31, 2024 | -$0.47 | N/A |
| Aug 31, 2023 | -$1.01 | N/A |
| Aug 31, 2022 | -$1.25 | N/A |
| Aug 31, 2021 | -$0.84 | N/A |
| Aug 31, 2020 | -$0.05 | N/A |
| Aug 31, 2019 | -$0.04 | N/A |
| Aug 31, 2018 | -$0.10 | N/A |
| Aug 31, 2017 | -$0.49 | N/A |
Frequently Asked Questions About LEXX
When is Lexaria Bioscience's next earnings date?
Lexaria Bioscience's next earnings report is expected for Nov 26, 2026.
Did LEXX beat earnings estimates last quarter?
No. Lexaria Bioscience reported EPS of -$0.08 for the quarter ended May 31, 2026, below the -$0.06 estimate by 33.33%.
What EPS do analysts expect from LEXX next quarter?
The consensus EPS estimate for Lexaria Bioscience for the quarter ended Aug 31, 2026 is -$0.92 from 3 analysts.
How often does LEXX beat earnings estimates?
Lexaria Bioscience beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -9.58%.
LEXX pages: Overview, Earnings, Financials